Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1581560

Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia

Author
BETTICHER, D. C1 ; RATSCHILLER, D1 ; CERNY, T1 ; SCHMITZ, S.-F. H2 ; VON ROHR, A3 ; HESS, U4 ; ZULIAN, G5 ; WERNLI, M6 ; TICHELLI, A7 ; TOBLER, A8 ; FEY, M. F1
[1] Institute of Medical Oncology, Inselspital Bern, Bern, United States
[2] SIAK Coordinating Centre, Bern, United States
[3] Division of Oncology, Hirslanden, Zürich, Switzerland
[4] Division of Oncology, St. Gallen, Switzerland
[5] Division of Oncology, Geneva, Switzerland
[6] Division of Oncology, Aarau, Switzerland
[7] Division of Haematology, Basel, Switzerland
[8] Division of Haematology, Bern, Switzerland
Source

Annals of oncology. 1998, Vol 9, Num 7, pp 721-726 ; ref : 24 ref

ISSN
0923-7534
Scientific domain
Medical oncology; Pharmacology drugs
Publisher
Oxford University Press, Oxford
Publication country
United Kingdom
Document type
Article
Language
English
Keyword (fr)
Anticancéreux Chimiothérapie Chronique Cladribine Efficacité traitement Homme Leucémie lymphoïde Posologie Relation dose réponse Récidivant Résistance Toxicité Voie intraveineuse Voie souscutanée Hémopathie maligne Lymphoprolifératif syndrome
Keyword (en)
Antineoplastic agent Chemotherapy Chronic Cladribine Treatment efficiency Human Chronic lymphocytic leukemia Posology Dose activity relation Recurrent Resistance Toxicity Intravenous administration Subcutaneous administration Malignant hemopathy Lymphoproliferative syndrome
Keyword (es)
Anticanceroso Quimioterapia Crónico Cladribina Eficacia tratamiento Hombre Leucemia linfoidea Posología Relación dosis respuesta Recidivante Resistencia Toxicidad Vía intravenosa Vía subcutánea Hemopatía maligna Linfoproliferativo síndrome
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
1581560

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web